Clinical predictors of postoperative recurrence in ovarian endometrioma: evaluation of follistatin expression

View at Publisher

Ask AI

Bookmark

Share

Key Points

This research aims to identify clinical predictors of recurrence after surgery for ovarian endometrioma and evaluate the role of follistatin expression.
Conducted a retrospective study of patients operated on for ovarian endometrioma from 2008 to 2013.
Analyzed demographic, clinical, and surgical data along with recurrence characteristics.
Assessed follistatin expression using immunohistochemistry with a binary scoring system.
Evaluated factors associated with recurrence using statistical analysis.
Out of 50 patients, 24 (48%) experienced recurrence after surgery.
Recurrence was significantly higher in advanced-stage disease (66.7% vs. 30.8%, p=0.034).
Previous surgery for endometriosis was more common in the recurrence group (50.0% vs. 3.8%, p<0.05).

We only have this paper's title and publication details.

Retrospective study identifies clinical data affecting ovarian endometrioma recurrence and follistatin expression implications.

No takes yet. Share an insight, caveat, or question.

Hanedan et al. (2026) studied this question.

View at Publisher

Ask AI

Bookmark

Share